BAYRY - Activist Bluebell steps up pressure for Bayer breakup supervisory board changes - report

2023-04-20 10:53:09 ET

• Activist investor Bluebell Capital Partners is reportedly renewing a call for German agriculture and drug company Bayer ( OTCPK:BAYRY ) to breakup and for a reshuffle of its supervisory board.
• Bluebell wants Bayer ( OTCPK:BAYRY ) to commit that the four supervisory board members who are up for re-election this year won't stand for re-election, according to an FT report, which cited a presentation the activist investor sent to the company this week. The activist wants the company to split its crop sciences and pharmaceuticals divisions.
• The latest report comes as Bayer's (BAYRY ) recently named CEO Bill Anderson is set to formally take the job in June and after Bloomberg reported in January that Bluebell had built an undisclosed stake and wants Bayer to separate its crop sciences business from its drug business.

For further details see: